Naegleria fowleri is a free-living amoeba commonly found in warm freshwater environments such as hot springs, lakes, natural mineral waters, and resort spas frequented by tourists. These amoebae can tolerate temperatures of up to 45 C. Infection with this parasite can cause primary amoebic meningoencephalitis (PAM), an acute and generally fatal disease of the central nervous system that has a rapid onset and typically results in death within a week or less. Although PAM is generally viewed as a very rare condition, the number of reported PAM cases is increasing each year. PAM is difficult to diagnose because the clinical signs of the disease are similar to those of bacterial meningitis.
Because it typically presents in healthy individuals, N. fowleri is not categorized as an opportunistic amoeba, as are Acanthamoeba and Balamuthia, but rather as a pathogen. PAM often occurs in healthy immunologically intact children and young adults who were exposed during recreational activity in warm bodies of freshwater. Typically, PAM occurs in the hot summer months, when large numbers of people engage in recreational aquatic activities in freshwater bodies that may harbor these amoebae.
Naegleria fowleri amoebae enter the human host via the nasal route when they are splashed or inhaled into the nose. Forcing water into the nose by diving or jumping into water is common, but N. fowleri can become motile even if the victim is simply submerged under water. Upon entering the nasal cavity, N. fowleri infect the olfactory mucosa and ascend the olfactory nerve through the cribiform plate until they reach the olfactory bulbs of the central nervous system.
Naegleria fowleri occurs worldwide and has been isolated from soil and fresh water. More than 30 species of Naegleria have been described based on the sequence of the SS rRNA gene, but only N. fowleri is known to cause infection in humans. In nature, these amoebae feed upon bacteria and have been isolated from freshwater pools, puddles, lakes, rivers, swimming pools, hot springs, thermally polluted effluents of power plants, hydrotherapy pools, aquaria, sewage, irrigation canals, and even from the the nasal passages and throats of healthy individuals. However, they have not been recovered from seawater.
Naegleria fowleri has been found in aquatic environments frequented by tourists inThailand and Japan, in swimming areas along rivers in Italy, in swimming pools and streams in Belgium and the former Czechoslovakia, in swimming pools in England and New Zealand, in hot springs in California and New Zealand, and in warm freshwater lakes throughout the southern United States.
Visvesvara et al. (2007) reviewed the diagnosis and pathophysiology of N. fowler infection, as well as public health strategies for monitoring and control. Heggie (2010) reviewed the epidemiology, diagnosis, pathophysiology, and treatment of N. fowler infection.
(Visvesvara et al. 2007; Heggie 2010 and references therein; Centers for Disease Control Parasites and Health website)
Naegleria fowleri // (also known as the "brain-eating amoeba") is a free-living, thermophylic excavate form of protist typically found in warm bodies of fresh water, such as ponds, lakes, rivers, and hot springs. It is also found in soil, near warm-water discharges of industrial plants, and unchlorinated or poorly chlorinated swimming pools in an amoeboid or temporary flagellate stage. There is no evidence of this organism living in salt water. It is an amoeba belonging to the phylum Percolozoa. N. fowleri can invade and attack the human nervous system and brain, causing primary amoebic meningoencephalitis (PAM). Although this occurs rarely, such an infection nearly always results in the death of the victim. The case fatality rate is greater than 95%.
- 1 Life cycle
- 2 Infectious disease
- 2.1 History
- 2.2 Signs and symptoms
- 2.3 Cause
- 2.4 Diagnosis
- 2.5 Epidemiology
- 2.6 Research
- 2.7 Society and culture
- 3 References
- 4 External links
Naegleria fowleri occurs in three forms: a cyst, a trophozoite (ameboid) and a flagellate. It does not form a cyst in human tissue. Only the amoeboid trophozoite stage exists in human tissue. The flagellate form can exist in the cerebrospinal fluid (CSF).
Trophozoites encyst due to unfavorable conditions. Factors that induce cyst formation can include food deprivation, crowding, desiccation, accumulation of waste products, and cold temperatures. N. fowleri has been found to encyst at temperatures below 10 °C/50F.
This reproductive stage of the protozoan organism, which transforms near 25 °C/77F and grows fastest at around 42 °C/106.7F, proliferates by binary fission. The trophozoites are characterized by a nucleus and a surrounding halo. They travel by pseudopodia, temporary round processes which fill with granular cytoplasm. The pseudopodia form at different points along the cell, thus allowing the trophozoite to change directions. In their free-living state, trophozoites feed on bacteria. In tissues, they phagocytize red blood cells and white blood cells and destroy tissue.
This biflagellate form occurs when trophozites are exposed to a change in ionic concentration, such as placement in distilled water. (The flagellate form does not exist in human tissue).The transformation of trophozoites to flagellate form occurs within a few hours.
Physicians M. Fowler and R. F. Carter first described human disease caused by amebo-flagellates in Australia in 1965. Their work on amebo-flagellates has provided an example of how a protozoan can effectively live both freely in the environment, and in a human host. Since 1965, more than 144 cases have been confirmed in different of countries. In 1966, Fowler termed the infection resulting from N. fowleri, primary amoebic meningoencephalitis (PAM) to distinguish this central nervous system (CNS) invasion from other secondary invasions made by other amoebae such as Entamoeba histolytica. A retrospective study determined the first documented case of PAM possibly occurred in Britain in 1909.
Signs and symptoms
Onset symptoms of infection start about five days (range is from one to seven days) after exposure. The initial symptoms include, but are not limited to, changes in taste and smell, headache, fever, nausea, vomiting, and stiff neck. Secondary symptoms include confusion, hallucinations, lack of attention, ataxia, and seizures. After the start of symptoms, the disease progresses rapidly over three to seven days, with death occurring usually from seven to fourteen days laterthough it can take longer. A recent case in Taiwan was that of a man who died after twenty five days.
In humans, N. fowleri invades the central nervous system via the nose (specifically through the olfactory mucosa and cribriform plate of the nasal tissues). It attaches itself to the olfactory nerve and migrates to the olfactory bulbs, where it feeds on the nerve tissue resulting in significant necrosis and hemorrhaging.From there, it migrates further along nerve fibres and enters the floor of the cranium via the cribriform plate and into the brain. The organism begins to consume cells of the brain, piecemeal, by means of an amoebostome, a unique actin-rich,sucking apparatus extended from its cell surface. It then becomes pathogenic, causing primary amoebic meningoencephalitis (PAM or PAME). PAM is a disease affecting the central nervous system. PAM usually occurs in healthy children or young adults with no prior history of immune compromise who have recently been exposed to bodies of fresh water.
Amphotericin B is effective against N. fowleri in vitro, but the prognosis remains bleak for those who contract PAM, and survival remains less than 1%. On the basis of the in vitro evidence alone, the Centers for Disease Control and Prevention (CDC), currently recommends treatment with amphotericin B for primary amoebic meningoencephalitis, but no evidence supports this treatment affecting outcome. Treatment combining miconazole, sulfadiazine, and tetracycline has shown limited success only when administered early in the course of an infection.An Iranian infant of five months was successfully treated with Amphotericin B and Rifampicin.
While miltefosine had therapeutic effects during an in vivo study in mice, chlorpromazine (Thorazine) showed to be the most effective substance – the authors concluded: "Chlorpromazine had the best therapeutic activity against N. fowleri in vitro and in vivo. Therefore, it may be a more useful therapeutic agent for the treatment of PAME than amphotericin B."
Untimely diagnoses remain a very significant impediment to the successful treatment of infection, as most cases have only been discovered post mortem. Infection killed 121 people in the United States from 1937 through 2007.
N. fowleri can be grown in several kinds of liquid axenic media or on non-nutrient agar plates coated with bacteria. Escherichia coli can be used to overlay the non-nutrient agar plate and a drop of cerebrospinal fluid sediment is added to it. Plates are then incubated at 37°C and checked daily for clearing of the agar in thin tracks, which indicate the trophozoites have fed on the bacteria. Detection in water is performed by centrifuging a water sample with E. coli added, then applying the pellet to a non-nutrient agar plate. After several days, the plate is microscopically inspected and Naegleria cysts are identified by their morphology. Final confirmation of the species' identity can be performed by various molecular or biochemical methods. Confirmation of Naegleria presence can be done by a so-called flagellation test, where the organism is exposed to a hypotonic environment (distilled water). Naegleria, in contrast to other amoebae, differentiates within two hours into the flagellate state. Pathogenicity can be further confirmed by exposure to high temperature (42 °C): Naegleria fowleri is able to grow at this temperature, but the nonpathogenic Naegleria gruberi is not.
In 2001, a first reported case of PAM was contracted by a five month old infant in Mangalore, South India. A second case of PAM in an infant was found in a six month old infant in South India, in 2005. Cases in infants are extremely rare since the usual known cause of infection is due to swimming in contaminated water.
A first reported case of PAM was diagnosed in a five month old male infant in Iran, in 2012. He was treated with Amphotericin B and Rifampicin and two months later he was asymptomatic.
From July to October 2012, 22 people in the southern part of Pakistan died within a week from Naegleria infection. At least 13 cases have been reported in Karachi, Pakistan, in patients who had no history of aquatic activities. Infection likely occurred through ablution with tap water. It may be attributed to rising temperatures, reduced levels of chlorine in potable water, or deteriorating water distribution systems.
In 1979, a girl swimming in the restored Roman bath in the English city of Bath swallowed some of the source water, and died five days later from PAM. Tests showed that N. fowleri was in the water, and the pool was closed permanently.
According to the Centers for Disease Control and Prevention, the protist killed 33 people between 1998 and 2007. In the 10 years from 2001 to 2010, 32 infections were reported in the U.S. Of those cases, 30 people were infected by contaminated recreational water and two people were infected by water from a geothermal (naturally hot) drinking water supply. Most cases over the years have been in the Southeast U.S. In 2011, there were two unusual cases in which Louisiana residents died after becoming infected by using neti pots with household tap water, the first U.S. cases of PAM linked to N. fowleri in household plumbing served by municipal water. Two years later, the St. Bernard Parish, Louisiana water system was found to contain N. fowleri after a 4-year-old died of the infection.  In 2013, a girl in Arkansas became the third known person in the last 50 years to survive the parasite after her doctors gave her an experimental drug, Miltefosine, in addition to the standard treatment. The amoeba was found in the DeSoto Parish, Louisiana Waterworks District No. 1. It was flushed with additional chlorine on October 9, 2013 to kill it.
In 1998, in Venezuela, a sixteen year old male died a week after becoming infected by Naegleria fowleri. There were two new cases reported in 2006. Two males, one ten years old and one twenty-three years old, both died within days of their hospital admittance.
This is not a comprehensive list, and cases are continuing to be reported. The incidence of infection itself is likely to increase as its range through climate change is increasing. In Minnesota, USA, in August 2010 during an exceptionally warm month, a seven year old contracted PAM which very quickly proved fatal. This was the first case reported in Minnesota, which is some 550 miles more northerly than the previous most northerly location noted for the infection. This gives support to the view of N.fowleri increasing its range as temperatures rise.Also, the numbers of reported cases will show an increase, simply in terms of better informed diagnoses being made in patients and also in autopsy findings.
Current research is focused on development of real time PCR diagnostic methods. One method being developed involves monitoring the amplification process in real time with hybridization[disambiguation needed] of fluorescent-labeled probes targeting the MpC15 sequence – which is unique to N. fowleri. Another group has multiplexed three real-time PCR reactions as a diagnostic for N. fowleri, as well as Acanthamoeba spp. and Balamuthia mandrillaris. This could prove to be an efficient diagnostic test.
As no effective treatment for PAM has been found, the development of a therapeutic is an area of great research interest. Currently, much work is being done to determine what factor specific to N. fowleri makes it pathogenic and if these virulence factors can be targeted by drugs. One potential factor in motility of the "amoeba" is the protein coded by Nfa1. When the Nfa1 gene is expressed in nonpathogenic N. gruberi and the amoebae are cocultivated with target tissue cells, the protein was found to be located on the food cup which is responsible for ingestion of cells during feeding. Following up that research, Nfa1 gene expression knockdown experiments were performed using RNA interference. In this experiment, double-stranded RNA (dsRNA) targeting the Nfa1 sequence was introduced and subsequently expression levels of the gene product dramatically decreased. This method could potentially be a technique applicable for knockdown of expression of pathogenicity factors in N. fowleri trophozoites.
|This section does not cite any references or sources. (August 2013)|
There is no licensed vaccine in the U.S. to protect against N. fowleri infection. However, because of the fatality of the ensuing meningoencephalitis, there are some efforts in vaccine research. Current research shows intranasal administration of Cry1Ac protoxin alone or in combination with amoebic Lysis increases protection against N. fowleri meningoencephalitis in mice. Studies are ongoing investigating whether the STAT6-induced Th2 immune response is essential for the resistance to N. fowleri infection, conferred by immunization with amoebic lysates plus Cry1Ac. Protected STAT6+/+-immunized mice elicited a Th2 type inclined immune response that produced predominantly humoral immunity; unprotected STAT6-/- mice exhibited a polarized Th1-type cellular response. These findings suggest that the STAT6-signalling pathway is critical for defense against N. fowleri infection. Immunization with Nfa1 protein on experimental murine PAM because of N. fowleri, BALB/c mice were intraperitoneally or intranasally immunized with a recombinant Nfa1 protein. The mean survival time of mice immunized intraperitoneally with rNfa1 protein was prolonged compared with controls (25.0 and 15.5 days, respectively).
Society and culture
N. fowleri was featured in the second season of House M.D. in the two-part episode "Euphoria (Part 1)" and "Euphoria (Part 2)". The amoeba was determined to be living in the water supply the deceased patient used to irrigate his marijuana garden.
The X-Files Season 1. Episode 20 "Darkness Falls" makes mention of "N. Fowleri".
The Animal Planet television series called Monsters Inside Me has twice run episodes on cases of N. fowleri. An August 2009 episode entitled "Hijackers" documented the story of how 11-year-old Will Sellars got infected with it by wakeboarding on a lake in Orlando, Florida, in July 2007. Another episode on November 30, 2012, told the story of 7-year-old Kyle Lewis of Arlington, Texas. 
- "The Centers for Disease Control and Prevention, Division of Parasitic Diseases – Naegleria FAQs". Retrieved 2012-01-14.
- "6 die from brain-eating amoeba after swimming". MSNBC. Associated Press. September 28, 2007.
- Cetin N, Blackall D.Naegleria fowleri meningoencephalitis.Blood 2012 Apr 19;119(16):3658.PMID 22645743
- Marciano-Cabral, F (1988). "Biology of Naegleria spp". Microbiological reviews 52 (1): 114–33. PMC 372708. PMID 3280964.
- Chang, SL (1978). "Resistance of pathogenic Naegleria to some common physical and chemical agents". Applied and environmental microbiology 35 (2): 368–75. PMC 242840. PMID 637538.
- Fowler, M; Carter, RF (1965). "Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report". British Medical Journal 2 (5464): 740–2. doi:10.1136/bmj.2.5464.734-a. PMC 1846173. PMID 5825411.
- Butt, Cecil G. (1966). "Primary Amebic Meningoencephalitis". New England Journal of Medicine 274 (26): 1473–6. doi:10.1056/NEJM196606302742605. PMID 5939846.
- Symmers, WC (1969). "Primary amoebic meningoencephalitis in Britain". British Medical Journal 4 (5681): 449–54. doi:10.1136/bmj.4.5681.449. PMC 1630535. PMID 5354833.
- CDC – 01 This Page Has Moved: CDC Parasites Naegleria
- Su MY, Lee MS,et al.A fatal case of Naegleria fowleri meningoencephalitis in Taiwan.Korean J Parasitol. 2013 Apr;51(2):203-6. doi: 10.3347/kjp.2013.51.2.203. Epub 2013 Apr 25. PMID 23710088
- Gautam PL, Sharma S et al. A rare case of survival from primary amebic meningoencephalitis.Indian Crit Care med.2012 Jan;16(1):34-6. doi: 10.4103/0972-5229.94432.PMID 22557831
- Marciano-Cabral, F; John, DT (1983). "Cytopathogenicity of Naegleria fowleri for rat neuroblastoma cell cultures: scanning electron microscopy study". Infection and immunity 40 (3): 1214–7. PMC 348179. PMID 6852919.
- Monsters Inside Me (2010-12-22). "Monsters Inside Me: The Brain-Eating Amoeba : Video : Animal Planet". Animal.discovery.com. Retrieved 2012-09-04.
- Centers for Disease Control and Prevention (CDC) (2008). "Primary amebic meningoencephalitis – Arizona, Florida, and Texas, 2007". MMWR. Morbidity and mortality weekly report 57 (21): 573–7. PMID 18509301.
- Bauman, Robert W. (2009). "Microbial Diseases of the Nervous System and Eyes". Microbiology, With Diseases by Body System (2nd ed.). San Francisco: Pearson Education. p. 617.
- Reference 23
- Kim, J.-H.; Jung, S.-Y.; Lee, Y.-J.; Song, K.-J.; Kwon, D.; Kim, K.; Park, S.; Im, K.-I. et al. (2008). "Effect of Therapeutic Chemical Agents In Vitro and on Experimental Meningoencephalitis Due to Naegleria fowleri". Antimicrobial Agents and Chemotherapy 52 (11): 4010–6. doi:10.1128/AAC.00197-08. PMC 2573150. PMID 18765686.
- Donald C. Lehman; Mahon, Connie; Manuselis, George (2006). Textbook of Diagnostic Microbiology (3rd ed.). Philadelphia: Saunders. ISBN 1-4160-2581-2.[page needed]
- Pougnard, C.; Catala, P.; Drocourt, J.-L.; Legastelois, S.; Pernin, P.; Pringuez, E.; Lebaron, P. (2002). "Rapid Detection and Enumeration of Naegleria fowleri in Surface Waters by Solid-Phase Cytometry". Applied and Environmental Microbiology 68 (6): 3102–7. doi:10.1128/AEM.68.6.3102-3107.2002. PMC 123984. PMID 12039772.
- Ccaronerva, L.; Novak, K. (1968). "Amoebic Meningoencephalitis: Sixteen Fatalities". Science 160 (3823): 92–92. doi:10.1126/science.160.3823.92. PMID 5642317.
- Shenoy S, Wilson G, Prashanth HV, et al.Primary meningoencephalitis by Naegleria fowleri: first reported case from Mangalore, South India.J Clin Microbiol. 2002 Jan;40(1):309-10.PMID 11773141
- Hebbar S, Bairy I, et al.Fatal case of Naegleria fowleri meningo-encephalitis in an infant: case report.Ann Trop Paediatr. 2005 Sep;25(3):223-6.PMID 16156990
- Gupta N, Bhaskar H, et al.Primary amoebic meningoencephalitis: first reported case from Rohtak, North India.National Institute of Communicable Diseases, New Delhi.PMID 20191204
- Movahedi Z, Shokrollahi MR,et al. Primary amoebic meningoencephalitis in an Iranian infant.Case Rep Med. 2012;2012:782854. doi: 10.1155/2012/782854. Epub 2012 Jul 26.PMID 22899941
- Cursons, R; Sleigh, J; Hood, D; Pullon, D (2003). "A case of primary amoebic meningoencephalitis: North Island, New Zealand". The New Zealand medical journal 116 (1187): U712. PMID 14752540.
- "At least 10 dies in Karachi due to Naegleria". Retrieved 2012-07-19.
- cdc.gov – Primary Amebic Meningoencephalitis Caused by Naegleria fowleri, Karachi, Pakistan, 2011-07-08
- "The City of Bath, Somerset, UK". H2G2. Retrieved 2007-11-01.
- Kilvington, Simon; John Beeching (June 1995). "Identification and epidemiological typing of Naegleria fowleri with DNA probes". Applied and Environmental Microbiology 61 (6): 2071–2078. PMC 167479. PMID 7793928. Retrieved 2007-10-31.
- "Naegleria – Frequently Asked Questions (FAQs)". Centers for Disease Control and Prevention. July 5, 2011. Retrieved 2011-08-17.
- Joelving, Frederick. "CDC strengthens brain-eating amoeba, neti pot link". Reuters. Retrieved 4 January 2013.
- Gholipour, Bahar. "Brain-Eating Amoeba: How One Girl Survived". livescience. Retrieved 28 August 2013.
- "Florida boy, 12, dies from brain-eating parasite, his family donated his organs wich were still good to save other lives.". CNN. Retrieved 24 August 2013.
- "Brain-eating amoeba detected in Louisiana parish's water, officials say". CNN. Retrieved 9 October 2013.
- Rodríguez R, Méndez O, et al.Central nervous system infection by free-living amebas: report of 3 Venezuelan cases.Rev Neurol. 1998 Jun;26(154):1005-8.PMID 9658480
- Petit F, Vilchez V, et al.Primary amebic meningoencephalitis: two new cases report from Venezuela. Arq Neuropsiquiatr 2006 Dec;64(4):1043-6.PMID 17221024
- Kemble SK, Lynfield R, et al.Fatal Naegleria fowleri infection acquired in Minnesota: possible expanded range of a deadly thermophilic organism.Clin Infect Dis. 2012 Mar;54(6):805-9. doi: 10.1093/cid/cir961. Epub 2012 Jan 11.PMID 22238170
- Kanwal, Farooqi M, Ali S, Ahmed SS.The paradox of primary amoebic meningoencephalitis--a rare disease, but commonly misdiagnosed.J PakMed Assoc2013 May;63(5):667.PMID 22238170
- Reference 38
- Maďarová, Lucia; Trnková, Katarína; Feiková, Soňa; Klement, Cyril; Obernauerová, Margita (2010). "A real-time PCR diagnostic method for detection of Naegleria fowleri". Experimental Parasitology 126 (1): 37–41. doi:10.1016/j.exppara.2009.11.001. PMID 19919836.
- Qvarnstrom, Y.; Visvesvara, G. S.; Sriram, R.; Da Silva, A. J. (2006). "Multiplex Real-Time PCR Assay for Simultaneous Detection of Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri". Journal of Clinical Microbiology 44 (10): 3589–95. doi:10.1128/JCM.00875-06. PMC 1594764. PMID 17021087.
- Song, K; Jeong, S; Park, S; Kim, K; Kwon, M; Im, K; Pak, J; Shin, H (2006). "Naegleria fowleri: Functional expression of the Nfa1 protein in transfected Naegleria gruberi by promoter modification". Experimental Parasitology 112 (2): 115–20. doi:10.1016/j.exppara.2005.10.004. PMID 16321386.
- Jung, S; Kim, J; Lee, Y; Song, K; Kim, K; Park, S; Im, K; Shin, H (2008). "Naegleria fowleri: nfa1 gene knock-down by double-stranded RNAs". Experimental Parasitology 118 (2): 208–13. doi:10.1016/j.exppara.2007.08.008. PMID 17904122.